
    
      The study enrolls 44 patients with Type 2 Diabetes in Zhongshan Hospital who are on treatment
      with insulin for at least 3 months. They are randomly allocated into 2 groups at a ratio of
      1:1 after screening for the inclusion and exclusion criteria. Patients in the Intervention
      group receive insulin regimen set by the AI assisted system and patients in Control group
      receive insulin regimen set by physicians. This study will be conducted in the Department of
      Endocrinology, Zhongshan Hospital,Fudan University and consist of a 7-day intervention
      period. Patient allocation will be stratified by HbA1c, BMI and previous total insulin
      doses.The primary endpoint is the percentage of time of sensor glucose measurements in
      targeted range (3.9-10 mmol/L) during the 7-days trial period.
    
  